Searching biomarkers for mental disorders—lessons from Alzheimer’s disease W. Maier Editorial 26 September 2016 Pages: 583 - 585
Mapping CSF biomarker profiles onto NIA–AA guidelines for Alzheimer’s disease Panagiotis AlexopoulosJennifer RoeslerRobert Perneczky Original Paper 08 August 2015 Pages: 587 - 597
Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer’s disease Vincenzo De LucaMaria Donata OrfeiGianfranco Spalletta Original Paper 29 December 2015 Pages: 599 - 606
Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer’s disease Fábio B. MuryWeber C. da SilvaEmmanuel Dias-Neto Original Paper 11 December 2015 Pages: 607 - 618
Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients Rosa Ayesa-ArriolaJosé Manuel Rodríguez-SánchezBenedicto Crespo-Facorro Original Paper 14 January 2016 Pages: 619 - 628
Using the cognitive assessment interview to screen cognitive impairment in psychosis Ana M. Sánchez-TorresMaría Rosa ElosúaManuel J. Cuesta Original Paper 06 June 2016 Pages: 629 - 637
General and social cognition in remitted first-episode schizophrenia patients: a comparative study Alice CaldiroliMassimiliano BuoliA. Carlo Altamura Original Paper 01 June 2016 Pages: 639 - 647
Restricted attention to social cues in schizophrenia patients Alexandra NikolaidesSusanne MiessStephan Ruhrmann Original Paper 15 June 2016 Pages: 649 - 661
Problem solving, impulse control and planning in patients with early- and late-stage Huntington’s disease Sabrina MörklNicole J. MüllerAnnamaria Painold Original Paper Open access 02 July 2016 Pages: 663 - 671
Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain Ioana IntaMiriam A. VogtDragos Inta Short Communication 19 October 2015 Pages: 673 - 677